ACRS · Aclaris Therapeutics, Inc.
$5.18
-0.15 (-2.81%)
At close · Jul 29
Market Cap
$744.41M
Shares
139.66M
Aclaris Therapeutics, Inc. Earnings Call Transcripts
Every quarterly earnings call for Aclaris Therapeutics, Inc. (ACRS) — the full transcript with speaker labels, the audio replay, AI call highlights and a management-tone score, plus the matching 8-K earnings release and the quarter's 10-Q or 10-K. Investor days and conferences appear here too.
Revenue & result across quarters
Revenue Net income YoY up YoY down artefacts
Conference
Investor event
2026-06-04
Jefferies Global Healthcare Conference
No reported result — non-financial event
Audio
Transcript
Slides
Conference
Investor event
2026-04-14
H.C. Wainwright 4th Annual Inflammatory Skin Disease Virtual Conference
No reported result — non-financial event
Audio
Transcript
Slides
Earnings call
FY24 · Q1
2024-05-07
Aclaris Therapeutics, Inc. Q1 FY2024 Earnings Call
Revenue
$2.40M
▼ 5.1% YoY Diluted EPS
$-0.24
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q1
2023-05-08
Aclaris Therapeutics, Inc. Q1 FY2023 Earnings Call
Revenue
$2.53M
▲ 74% YoY Diluted EPS
$-0.42
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY19 · Q4
2020-02-25
Aclaris Therapeutics, Inc. Q4 FY2019 Earnings Call
Revenue
$1.09M*
▼ 70.2% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Showing 1–5 of 5 earnings calls
Key facts
CIK
1557746
CUSIP
00461U105
13F (30d)
18 filings
18 filers
Visit website
Investor relations